Matt focuses on complex commercial litigation, representing clients in IP, contract, and regulatory litigation in federal and state court. He has significant expertise in federal jurisdiction and procedure. Matt is at home digging out case-changing evidence, crafting legal strategies under arcane statutes and procedures, eliciting critical deposition or trial testimony, and arguing on his feet to courts and arbitrators, all to help his clients win needed relief. Matt was honored as a 2020 Pegasus Scholar by American Inns of Court. In one of his favorite areas of complex litigation, Best Lawyers in America named Matt "One to Watch," and Thomson Reuters' Super Lawyers recognized him as a "Texas Rising Star" in IP Litigation. Based on recent pro bono work, Matt also is recognized as an authority in the byzantine federal regulatory scheme relating to cannabis research, even being named to the Law360 2020 Cannabis Editorial Advisory Board. Before joining the firm, Matt was a judicial clerk to the Hon. Rodney Gilstrap, U.S. District Judge for the Eastern District of Texas, spending hundreds of hours in court helping manage one of the busiest trial dockets in the country. Before then he was a litigator with Paul, Weiss in New York City.

Cynthia L. Meyer is a partner at Kleinfeld, Kaplan & Becker, LLP, whose practice focuses on FDA law and advertising law.  She regularly provides counsel to and advocates on behalf of clients in FDA-regulated industries, particularly in the dietary supplement, food, cosmetic, and pharmaceutical industries.  She advises on legal and regulatory matters involving various federal and state agencies, including the US Food and Drug Administration, Federal Trade Commission (FTC), US Department of Agriculture (USDA), and Consumer Product Safety Commission (CPSC), and has represented clients in advertising disputes in front of the National Advertising Division (NAD).

Cynthia frequently speaks and writes on a host of FDA and advertising issues, including dietary supplement labeling and structure-function claims requirements, advertising claims substantiation, and the regulation of hemp/CBD. She has authored or co-authored chapters and articles in multiple publications, such as A Practical Guide to FDA’s Food and Drug Law Regulation (multiple editions), Bringing Your Pharmaceutical Drug to Market (2015), and Law360. She currently serves on the Food and Drug Law Journal Editorial Advisory Board and has previously served on the Food and Drug Law Institute’s Advertising & Promotion for Medical Products committee and its Food Advertising, Labeling, and Litigation committee.  Cynthia has also been recognized in the 2022 edition of The Best Lawyers in America® for FDA Law.

Cynthia received her J.D. from Georgetown University Law Center and her B.S. in biology from Duke University.

Forbes Magazine dubbed Chelsie Spencer the “rare friendly face in the midst of a cutthroat CBD hurricane, the person you want on speed dial when things turn sour” for her work in the cannabidiol (CBD) industry. As head of the cannabis practice at Ritter Spencer Cheng PLLC, Chelsie represents clients in every facet of the cannabis and hemp industries, including dispensaries, growers, processors, manufacturers, retailers, and more for their business needs. Her transactional practice focuses on licensing, regulatory compliance, and other business matters. She frequently writes, speaks, and presents on issues affecting the cannabis industry at conferences and forums across the United States.

In addition to her representation of cannabis clients, Chelsie is an experienced trademark attorney. She has successfully secured registration of numerous federal trademarks for her clients and manages worldwide trademark portfolios. Her trademark practice also encompasses transactional issues such as trademark licensing, consent and coexistence agreements, and assignments. Chelsie is nationally recognized for her trademark work with cannabis clients across the United States.

Chelsie has been recognized as a Super Lawyer in the Cannabis practice area by Thomson Reuters and has been awarded the Client Champion distinction by Martindale-Hubbell. She is President of the Texas Hemp Legal Fund, serves as Chair of the International Cannabis Bar Association’s Amicus Committee, and serves as Vice President on the Board of Directors for the Texas Cannabis Council. She has helped draft cannabis legislation at both the federal and state levels and routinely advises state legislatures in regard to crafting effective cannabis policies.